Sanj K. Patel, Chairman & CEO at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 100,129 shares at $23.04 ($2.3M) on 2021-02-09, disclosed to the SEC on 2021-02-10.
Open-market sale of $2.3M KNSA by Chairman & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.00 | 4,528 | $104K | 4.5% |
| 2 | $23.00 | 4,924 | $113K | 4.9% |
| 3 | $23.04 | 20,401 | $470K | 20.4% |
| 4 | $23.04 | 20,401 | $470K | 20.4% |
| 5 | $23.08 | 23,569 | $544K | 23.6% |
| 6 | $23.08 | 23,569 |
| $544K |
| 23.6% |
| 7 | $23.06 | 1,600 | $37K | 1.6% |
| 8 | $23.07 | 1,137 | $26K | 1.1% |
| Total | $23.06 avg | 100,129 | $2.3M | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |